Peripheral venous catheters: an under-evaluated problem.

Peripheral venous catheters (PVC) are the most frequently used invasive devices in hospitals. Up to 70% of patients require a peripheral venous line during their hospital stay, and conservative estimates suggest that PVC days account for 15-20% of total patient days in acute care hospitals. Most published studies focus on thrombophlebitis and address the issue of scheduled catheter change, but there is still no consensus on the optimal time point for PVC change, or whether catheter replacement is required at all. Although PVC-associated catheter-related bloodstream infections (PVC-BSI) are far more serious than thrombophlebitis, few studies address this issue, and a large multicentre trial is lacking. Some studies on thrombophlebitis mention that no, or only a few, PVC-BSIs were identified, but such results must be interpreted with caution. Current data available on PVC-BSI suggest incidence density rates of 0.2-0.7 episodes per 1000 device days, which appear low when compared with other catheters. However, some studies report absolute PVC-BSI numbers in the range of central line-associated infections. It remains unclear whether PVC-BSI should be considered a serious healthcare problem or simply a very rare event. More research is needed both to capture the dimension of the problem and to provide efficient control measures.

[1]  G. Bearman,et al.  Impact of 2 different levels of performance feedback on compliance with infection control process measures in 2 intensive care units. , 2008, American journal of infection control.

[2]  S. Z. Abbas,et al.  Use and complications of peripheral vascular catheters: a prospective study. , 2007, British journal of nursing.

[3]  J. B. Martínez,et al.  [Intravenous cannulae: complications arising from their use and analysis of their predisposing factors]. , 1994, Medicina clinica.

[4]  C. McLaren,et al.  Intravenous Therapy Team and Peripheral Venous Catheter—Associated Complications: A Prospective Controlled Study , 1984 .

[5]  F. Haddad,et al.  Peripheral venous catheter-related inflammation. A randomized prospective trial. , 2006, Le Journal medical libanais. The Lebanese medical journal.

[6]  D. Pettit,et al.  The use of gauze versus transparent dressings for peripheral intravenous catheter sites. , 1995, The Nursing clinics of North America.

[7]  G P Samsa,et al.  Transparent polyurethane film as an intravenous catheter dressing. A meta-analysis of the infection risks. , 1992, JAMA.

[8]  A. Daneman,et al.  A Randomized, Controlled Trial of Heparin Versus Placebo Infusion to Prolong the Usability of Peripherally Placed Percutaneous Central Venous Catheters (PCVCs) in Neonates: The HIP (Heparin Infusion for PCVC) Study , 2007, Pediatrics.

[9]  J. Coia,et al.  Multi-centre research surveillance project to reduce infections/phlebitis associated with peripheral vascular catheters. , 2000, The Journal of hospital infection.

[10]  R. D. McCormick,et al.  Guidelines for the Prevention of Intravascular Catheter–Related Infections , 2002, Infection Control & Hospital Epidemiology.

[11]  M. Ringer,et al.  Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters. Gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. , 1987, JAMA.

[12]  M. Schrappe,et al.  Phlebitis Rate and Time Kinetics of Short Peripheral Intravenous Catheters , 2004, Infection.

[13]  James A. Evans,et al.  Ultrasonographic investigation of the pathogenesis of infusion thrombophlebitis , 1997, The British journal of surgery.

[14]  J. Macfie,et al.  Prospective study of the aetiology of infusion phlebitis and line failure during peripheral parenteral nutrition , 1996 .

[15]  M. Monreal,et al.  Infusion phlebitis in patients with acute pneumonia: a prospective study. , 1999, Chest.

[16]  FC Cheah,et al.  Randomized controlled trial of heparin for prevention of blockage of peripherally inserted central catheters in neonates , 2002, Acta paediatrica.

[17]  P. Ravert,et al.  Peripheral Intravenous Catheters Started in Prehospital and Emergency Department Settings , 2008, Journal of trauma nursing : the official journal of the Society of Trauma Nurses.

[18]  L. Gorski Infusion nursing standards of practice. , 2007, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[19]  D. Nelson,et al.  The natural history of teflon catheter-associated phlebitis in children , 1987 .

[20]  J. Collin,et al.  INFUSION THROMBOPHLEBITIS , 1975, The Lancet.

[21]  M. Monreal,et al.  Infusion Phlebitis in Post-Operative Patients: When and Why , 2000, Pathophysiology of Haemostasis and Thrombosis.

[22]  White Sa Peripheral intravenous therapy-related phlebitis rates in an adult population. , 2001 .

[23]  Dan M. Kluger,et al.  The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. , 2006, Mayo Clinic proceedings.

[24]  M. Ringer,et al.  Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. , 1991, Annals of internal medicine.

[25]  C. M. Cotten,et al.  Association between thrombosis and bloodstream infection in neonates with peripherally inserted catheters. , 2008, Thrombosis research.

[26]  H. Mckean,et al.  Double-blind study to investigate methods to prevent cephalothin-induced phlebitis. , 1977, American journal of hospital pharmacy.

[27]  K. Tripepi-Bova,et al.  A comparison of transparent polyurethane and dry gauze dressings for peripheral i.v. catheter sites: rates of phlebitis, infiltration, and dislodgment by patients. , 1997, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[28]  O. Cornely,et al.  Peripheral Teflon Catheters: Factors Determining Incidence of Phlebitis and Duration of Cannulation , 2002, Infection Control & Hospital Epidemiology.

[29]  A. Basar,et al.  Relevance and complications of intravenous infusion at the emergency unit at Nice university hospital. , 2003, The Journal of infection.

[30]  Clinical predictors of infection of central venous catheters used for total parenteral nutrition. , 1990 .

[31]  S. Kahn,et al.  The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. , 2002, The American journal of medicine.

[32]  L. Leibovici Daily change of an antiseptic dressing does not prevent infusion phlebitis: a controlled trial. , 1989, American journal of infection control.

[33]  T. Elliott,et al.  An audit of peripheral catheter care in a teaching hospital. , 1996, The Journal of hospital infection.

[34]  B. Barry,et al.  Impact d’un programme prolongé d’amélioration continue de la qualité sur le risque infectieux lié aux cathéters veineux périphériques , 2009 .

[35]  L. Wahren,et al.  Peripheral intravenous lines: time in situ related to complications. , 1996, Journal of intravenous nursing : the official publication of the Intravenous Nurses Society.

[36]  E. Uslusoy,et al.  Predisposing factors to phlebitis in patients with peripheral intravenous catheters: A descriptive study , 2008, Journal of the American Academy of Nurse Practitioners.

[37]  D. Maki,et al.  Infection control in intravenous therapy. , 1973, Annals of internal medicine.

[38]  M. McMahon,et al.  Influence of catheter type on occurrence of thrombophlebitis during peripheral intravenous nutrition , 1992, The Lancet.

[39]  K. K. Lai Safety of prolonging peripheral cannula and i.v. tubing use from 72 hours to 96 hours. , 1998, American journal of infection control.

[40]  B. Wakefield,et al.  Relationship Between Peripheral Intravenous Catheter Dwell Time and the Development of Phlebitis and Infiltration , 2001, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[41]  A. Charlett,et al.  Device-related sources of bacteraemia in English hospitals--opportunities for the prevention of hospital-acquired bacteraemia. , 2003, The Journal of hospital infection.

[42]  A. Hornero,et al.  Clinical epidemiology and outcomes of peripheral venous catheter-related bloodstream infections at a university-affiliated hospital. , 2007, The Journal of hospital infection.

[43]  D. Maki Preventing infection in intravenous therapy. , 1976, Hospital practice.

[44]  L. Campbell,et al.  I.v.-related phlebitis, complications and length of hospital stay: 1. , 1998, British journal of nursing.

[45]  P. Lambert,et al.  Efficacy of Adding 2% (w/v) Chlorhexidine Gluconate to 70% (v/v) Isopropyl Alcohol for Skin Disinfection Prior to Peripheral Venous Cannulation , 2008, Infection Control & Hospital Epidemiology.

[46]  P B Gaukroger,et al.  Infusion Thrombophlebitis: A Prospective Comparison of 645 Vialon® and Teflon® Cannulae in Anaesthetic and Postoperative Use , 1988, Anaesthesia and intensive care.

[47]  D. Nelson,et al.  Infectious complications during peripheral intravenous therapy with Teflon catheters: a prospective study. , 1987, The Pediatric infectious disease journal.

[48]  S. Roberts,et al.  The Auckland City Hospital Device Point Prevalence Survey 2005: utilisation and infectious complications of intravascular and urinary devices. , 2007, The New Zealand medical journal.

[49]  E Simchen,et al.  An epidemiologic study of the risks associated with peripheral intravenous catheters. , 1983, American journal of epidemiology.

[50]  Benjamin A Lipsky,et al.  A prospective study of Staphylococcus aureus nasal colonization and intravenous therapy-related phlebitis. , 1992, Archives of internal medicine.

[51]  W. Dunne,et al.  Peripheral intravenous catheter complications in critically ill children: a prospective study. , 1992, Pediatrics.

[52]  A. Valleron,et al.  [Complications due to peripheral venous catheterization. Prospective study]. , 2003, Presse medicale.

[53]  D. Maki,et al.  Steel needles used for intravenous therapy. Morbidity in patients with hematologic malignancy. , 1980, Archives of internal medicine.

[54]  R A Weinstein,et al.  Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. , 1998, Archives of internal medicine.

[55]  C. S. Nelson Advances in Pediatrics. Volume 33 , 1987 .

[56]  Oded Olsha,et al.  Prospective surveillance of phlebitis associated with peripheral intravenous catheters. , 2006, American journal of infection control.

[57]  Joan Webster,et al.  Bullous pemphigoid and pemphigus vulgaris—incidence and mortality in the UK: population based cohort study , 2008, British medical journal.

[58]  P. Collignon Intravascular catheter associated sepsis: a common problem , 1994 .

[59]  W. J. Russell,et al.  A Prospective Clinical Comparison of Two Intravenous Polyurethane Cannulae # , 1996, Anaesthesia and intensive care.

[60]  L. Jorfeldt,et al.  The care and handling of peripheral intravenous cannulae on 60 surgery and internal medicine patients: an observation study. , 1993, Journal of advanced nursing.

[61]  C. Woodhouse Infusion thrombophlebitis: the histological and clinical features. , 1980, Annals of the Royal College of Surgeons of England.

[62]  T. Karrison,et al.  Safety of Peripheral Intravenous Catheters in Children , 1999, Infection Control & Hospital Epidemiology.

[63]  W. Tan,et al.  Reducing Infusion Phlebitis in Singapore Hospitals Using Extended Life End-Line Filters , 2002, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[64]  I. Odenholt,et al.  Antibiotics Differ in Their Tendency to Cause Infusion Phlebitis: A Prospective Observational Study , 2002, Scandinavian journal of infectious diseases.

[65]  Sanjay Saint,et al.  Guidelines for the prevention of intravascular catheter-related infections. , 2002, American journal of infection control.

[66]  F. Lederle,et al.  The Idle Intravenous Catheter , 1992, Annals of Internal Medicine.

[67]  Homer Ld,et al.  Risks associated with 72- and 96-hour peripheral intravenous catheter dwell times. , 1998 .

[68]  M. Beach,et al.  Consequences of intravascular catheter sepsis. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[69]  D. Goldmann,et al.  Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. , 1995, The Pediatric infectious disease journal.

[70]  J. Doig,et al.  The Misuse of Intravenous Cannulae , 1988, Scottish medical journal.

[71]  T. Bregenzer,et al.  Is routine replacement of peripheral intravenous catheters necessary? , 1998, Archives of internal medicine.

[72]  P. Myles,et al.  Single versus Double Occlusive Dressing Technique to Minimize Infusion Thrombophlebitis: Vialon® and Teflon® Cannulae Reassessed , 1991, Anaesthesia and intensive care.

[73]  Varinder Singh,et al.  Peripheral IVs: Factors Affecting Complications and Patency—A Randomized Controlled Trial , 2008, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[74]  Jessica M. Powell,et al.  The Relationship Between Peripheral Intravenous Catheter Indwell Time and the Incidence of Phlebitis , 2008, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[75]  J. Macfie,et al.  A prospective and randomised study comparing the incidence of infusion phlebitis during continuous and cyclic peripheral parenteral nutrition. , 1991, Clinical nutrition.

[76]  Y. Dikmen,et al.  The value of Gram staining of catheter segments for rapid detection of peripheral venous catheter infections. , 2006, Diagnostic microbiology and infectious disease.